Innovative Collaborations to Speed Science to Patients

11:00 AM - 12:00 PM, Wednesday, June 5,2019 ・ 112AB, Level 100
The session will address: • Why deprioritized compounds still offer the potential to help address unmet medical needs for certain patient communities and are worth advancing. • Barriers to developing medicines for specific patient populations and how to get innovation to where it’s needed. • Different mechanisms for bringing products to market by affiliating with organizations that can improve access. • What’s changing with the traditional model and why now is the right time for change.
Speakers
photo
President
Children’s Tumor Foundation
photo
Executive Director
FasterCures, Milken Institute
photo
Managing Director
Bain Capital Life Sciences
photo
Chief Executive Officer
LifeArc